Daihan Pharmaceutical Co., Ltd. (023910)

Overview

Daihan Pharmaceutical Co., Ltd. has a long-established history since its founding in 1945, positioning itself as a significant player in South Korea's pharmaceutical sector. This company dedicates itself to the development, manufacture, and sale of a wide array of therapeutic drugs aimed at improving patient healthcare outcomes. Operating with its headquarters in Seoul, South Korea, Daihan Pharmaceutical has committed itself to uphold high standards of quality and innovation in its product offerings. Its portfolio comprises a comprehensive selection of prescription medications, over-the-counter (OTC) drugs, and quasi-drugs, catering to various healthcare needs. Additionally, Daihan Pharmaceutical extends its expertise to the provision of infusion-related solutions, ensuring a holistic approach to medication and treatment options. This company's steadfast commitment to research and development underscores its mission to advance healthcare solutions that can contribute significantly to the well-being of communities it serves.

Products and Services

Daihan Pharmaceutical Co., Ltd. offers a diversified range of products and services designed to meet the intricate needs of healthcare and medical treatment. These include:

• Prescription Drugs: A vast assortment of prescription medications formulated to address a variety of medical conditions, ensuring efficacy and safety in treatment protocols. These drugs undergo rigorous testing and verification processes to meet the therapeutic needs of patients.
• Over-The-Counter (OTC) Drugs: Accessible and convenient healthcare solutions for common ailments and health issues. OTC drugs from Daihan Pharmaceutical offer reliable relief and are available without the need for a prescription, emphasizing customer convenience and care.
• Quasi-Drugs: Products that occupy the space between cosmetics and pharmaceuticals, including health supplements and other items designed to promote overall well-being without the direct intention for disease treatment. These quasi-drugs are tailored to improve quality of life and support daily health management.
• Infusion-Related Solutions: Specialized solutions aimed at supporting infusion therapies, crucial for the administration of drugs directly into the bloodstream. Daihan Pharmaceutical's infusion-related solutions enhance the effectiveness and comfort of such treatments, showcasing the company’s commitment to innovative healthcare practices.